Seroprevalence of SARS-CoV2 in Qatar: a longitudinal epidemiological study
Date
2020Author
Shurrab, FarahAl-Jighefee, Hadeel
Younes, Salma
Al-Sadeq, Duaa
Althani, Asmaa
Yassine, Hadi
Syed, Mohamed
AlNuami, Ahmed
Qotba, Hamda
Nasrallah, Gheyath
...show more authors ...show less authors
Metadata
Show full item recordAbstract
In Qatar, the first COVID-19 cases were reported on the 29th of February 2020, and the numbers increased dramatically within few months. Primary Health Care Corporation in collaboration with Qatar University's Biomedical Research Centre initiated a three-phase longitudinal epidemiological study to obtain precise estimates of point and period prevalence by age, gender and nationality. The first phase of the study is done and included 2084 individuals. The results showed that the overall prevalence was 11.1%. However, the point prevalence and the period prevalence of SARS-CoV2 was 1.6 and 9.5 % resp. IgG prevalence was higher amongst 18-39-year old (10 %) and ? 60 (11.9 %), and higher in males (11.6 %) compared with females (6.2 %), and higher incidences were reported among Highest amongst North African (10.9 %) and Southern Asian (15.1 %) nationalities.
DOI/handle
http://hdl.handle.net/10576/16516Collections
- COVID-19 Research [798 items ]
- Theme 5: Covid-19 Research [32 items ]